Surprise! Medicare Co-Pays Slashed on 13 Drugs
Surprise! Medicare Co-Pays Slashed on 13 Drugs
Biden’s Inflation Reduction Act is putting money in seniors’ pockets quicker than expected. A federal judge has already sided with the plan, agreeing that the government can negotiate prices for Americans.
It looks like Medicare’s drug insurers see the writing on the wall—they’ll cut prices on 13 drugs beginning in 2024. That beats the negotiated terms by two years! The cuts are steep: co-pays will be free or $11 on these medicines, down from $30-$50.
AARP says that one in five older adults skip prescriptions or doses to save money. According to Maya Golden’s exclusive report on Axios, these are the drugs you’ll be saving on next year.
Entresto
Photo Credit: Shutterstock.
Entresto (released in 2015) treats long-lasting (chronic) heart failure. It’s increased in price 78% since it hit the market.
Jardiance
Photo Credit: Shutterstock.
Jardiance (released in 2014) treats type 2 diabetes. It’s increased in price 97% since it hit the market.
Januvia
Photo Credit: Shutterstock.
Januvia (released in 2006) treats type 2 diabetes. It’s increased in price 275% since it hit the market.
Xarelto
Photo Credit: Shutterstock.
Xarelto (released in 2011) is a blood thinner. It’s increased in price 168% since it hit the market.
Eliquis
Photo Credit: Shutterstock.
Eliquis (released in 2012) is a blood thinner. It’s increased in price 124% since it hit the market.
Farxiga
Photo Credit: Shutterstock.
Farxiga (released in 2014) is the brand name for dapagliflozin and treats type 2 diabetes, chronic kidney disease, and heart disease.
Xigduo
Photo Credit: Shutterstock.
Xigduo is a combination of dapagliflozin and metformin that’s used to treat type 2 diabetes.
Jentadueto
Photo Credit: Shutterstock.
Jentadueto is a combination of linagliptin and metformin that’s used to treat type 2 diabetes.
Tradjenta
Photo Credit: Shutterstock.
Tradjenta is the brand name for linagliptin, which is used to treat type 2 diabetes.
Synjardy
Photo Credit: Shutterstock.
Synjardy is a combination of empagliflozin and metformin that’s used to treat type 2 diabetes.
Glyxambi
Photo Credit: Shutterstock.
Glyxambi is a combination of empagliflozin and linagliptin that’s used to treat type 2 diabetes.
Trijardy
Photo Credit: Shutterstock.
Trijardy is a combination of empagliflozin, linagliptin, and metformin that’s used to treat type 2 diabetes.
Janumet
Photo Credit: Shutterstock.
Janumet is a combination of sitagliptin and metformin that’s used to treat type 2 diabetes.
14 Countries with Better Healthcare Than the United States
Photo Credit: Shutterstock.
In some cases, countries have much better outcomes than the United States, and in others, countries have marginally worse outcomes but much more affordable, accessible care. Learn about 14 countries with better healthcare than the US where you can immigrate.
➤ 14 Countries with Better Healthcare Than the United States
10 Countries Where You Can Retire With $2,000/Month
Photo Credit: Shutterstock.
Are you looking forward to retirement? Do you imagine peaceful days spent socializing with family and friends, pursuing hobbies, and catching up on things you put off during a long career with limited time off?
While we all long for those days, you may look at your bank account and bills and wonder if they’ll ever come. If retiring in the U.S. feels unattainable, there are options for moving abroad that may be within your budget.
➤ 10 Countries Where You Can Retire With $2,000/Month
Jen is the co-founder of Expatsi, a company that helps Americans move abroad. She created the Expatsi Test, an assessment that recommends countries for aspiring emigrants based on lifestyle data. Jen has an MBA from Emory University with concentrations in marketing and innovation. She's written for BusinessWeek, Health, Cooking Light, and Southern Living. Prior to Expatsi, she created Freshfully and Bottle & Bone—two businesses in the local food space—and spoke at TEDx on being brave. She's moving to Mexico in 2024, along with her husband and co-founder Brett, pitbull mix Squiggy, and three rotten cats. How can she help you move abroad?
Related Posts
Jen is the co-founder of Expatsi, a company that helps Americans move abroad. She created the Expatsi Test, an assessment that recommends countries for aspiring emigrants based on lifestyle data. Jen has an MBA from Emory University with concentrations in marketing and innovation. She's written for BusinessWeek, Health, Cooking Light, and Southern Living. Prior to Expatsi, she created Freshfully and Bottle & Bone—two businesses in the local food space—and spoke at TEDx on being brave. She's moving to Mexico in 2024, along with her husband and co-founder Brett, pitbull mix Squiggy, and three rotten cats. How can she help you move abroad?